Another worth-noting example is RNO.
Its third quarter revenue is $159k, based on which its annual revenue is only 0.6millions. Its market cap is already $22 millions. While its partnership with Resmed helps its growth prospect, but to me, its technology is quite imitable.
CMP's revenue about 33millions and market cap 40 millions, only twice of RNO. But, the contrast of 33millions sales to 0.6 millions is 55 times. And, CMP's technology is much well established.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
0.005(1.79%) |
Mkt cap ! $54.78M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.5¢ | 28.0¢ | $1.46K | 5.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19300 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 20999 | 1 |
View Market Depth
| Last trade - 14.20pm 21/07/2025 (20 minute delay) ? |
| CMP (ASX) Chart |